Skip to content
Search

Latest Stories

Bowel Cancer Awareness Month: Blood in your poo and other warning signs

Bowel Cancer Awareness Month: Blood in your poo and other warning signs

Early detection of bowel cancer significantly improves the chances of successful treatment and survival

Bowel cancer is the fourth most common cancer in the UK, with around 42,000 people diagnosed with the disease every year, according to Bowel Research UK.

The Department of Health and Social Care (DHSC) has reported a decline in the number of deaths due to bowel cancer in recent decades, primarily attributed to early detection of the disease.


If diagnosed at the earliest stage, it is estimated that nine out of ten bowel cancer patients survive the disease for five years or longer.

Although most cases of bowel cancer occur in individuals over 50, it can also affect younger people. Therefore, Bowel Research UK encourages everyone to watch out for possible signs and symptoms, as early detection is crucial for effective treatment.

As April is designated as Bowel Cancer Awareness Month, various health organisations and research charities, including the NHS, Cancer Research UK, Bowel Can UK, Bowel Research UK, are using social media platforms to educate the public about the most common bowel cancer symptoms.

Bowel cancer, also known as colorectal cancer, is a type of cancer that can occur anywhere in the large intestine, which includes both the colon and rectum.

Signs and symptoms of bowel cancer can include:

  • Blood in your poo or bleeding from your bottom
  • Changes in your bowel habits poo (needing to poo more or less often, often feeling like you need to poo, having diarrhoea or constipation)
  • Feeling more tired or breathless than usual
  • Unexpected weight loss
  • Tummy pain or bloating.

It is advisable to speak to your GP if you experience any of these symptoms over three or more weeks.

NHS bowel cancer screening 

Under an NHS bowel cancer screening programme, everyone aged 56 to 74 registered with a GP in England is automatically sent a home test kit, called a faecal immunochemical test (FIT), every two years.

With this kit, a small faecal sample is collected and sent to a lab. It is then examined for traces of blood. If the test detects anything unusual, the patient may be advised to undergo additional tests at the hospital to confirm or rule out cancer.

The kit can detect signs of cancer before you notice anything is wrong.

The programme, which started in April 2021, is expanding to make the kit available to everyone aged 50 to 55 years by 2025.

What causes bowel cancer?

As per the NHS, the exact cause of bowel cancer is not always clear, but it can result from genetic changes, lifestyle, and environmental factors.

People with certain health conditions such as inflammatory bowel disease (Crohn's disease and ulcerative colitis), bowel polyps (small growths in your bowel), and Lynch Syndrome or familial adenomatous polyposis may be more likely to get bowel cancer.

Individuals aged over 50, smokers, and those who are overweight are also known to be at higher risk of developing bowel cancer.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less